First application of hemi-body electron beam irradiation for Kaposi sarcoma at the lower extremities

Kalliopi Platoni, Stefanos Diamantopoulos, Maria Dilvoi, Panagiotis Delinikolas, Efrosyni Kypraiou, Efstathios Efstathopoulos, Vassilios Kouloulias

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
41 Downloads (Pure)


Kaposi’s sarcoma (KS) is a systemic neoplastic disease that can present cutaneous symptoms and is usually treated with a systematic approach due to its extent. Due to its radiosensitivity, radiotherapy is considered one of its main treatments, for palliation and local control of the skin and mucosal lesions. The aim of this paper was to report the first case of KS treated by hemi-body electron irradiation protocol in Greece. A fractionated 40 Gy hemi-body electron irradiation was prescribed to a 60-year-old male patient with KS at his legs. Dose uniformity was verified on a daily basis by thermo luminescence dosimetry (TLD). The treatment resulted to complete clinical response. Limited irradiation-derived side effects appeared. This is the first case ever to be treated with hemi-body electron irradiation protocol in Greece. To the best of our knowledge, this is also the first time that a single field hemi-body electron beam irradiation at a total skin electron beam (TSEB)-like configuration is reported to be used for KS.
Original languageEnglish
Pages (from-to)268-272
Number of pages5
Issue number1
Publication statusPublished - 28 Feb 2018


  • hemi-body electron beam irradiation
  • radiotherapy
  • kaposi sarcoma

Cite this